Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel immune checkpoint targets: A promising therapy for cancer treatments
Mohsina Patwekar, Nouroz Sehar, Faheem Patwekar, et al.
International Immunopharmacology (2023) Vol. 126, pp. 111186-111186
Closed Access | Times Cited: 20

Showing 20 citing articles:

Assessment of Anticancer Properties of Thai Plants
Bancha Yingngam
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 122-164
Closed Access | Times Cited: 13
Extracellular Vesicles, Circulating Tumor Cells, and Immune Checkpoint Inhibitors: Hints and Promises
Sara Bandini, Paola Ulivi, Tania Rossi
Cells (2024) Vol. 13, Iss. 4, pp. 337-337
Open Access | Times Cited: 6
A comprehensive prognostic and immune analysis of LAPTM4B in pan-cancer and Philadelphia chromosome-positive acute lymphoblastic leukemia
Hui Zhou, Yuyao Yi, Wei He, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Therapeutic effects of NK cell-derived EVs on cancer: Current advances and future treatment strategies
Mehtap Kızılpınar, Mohammadreza Dastourı
(2025) Vol. 2, Iss. 1, pp. 10-24
Closed Access
Liver Transplantation for Non-Hepatocellular Carcinoma: Role of Immune Checkpoint Inhibitors
Pegah Bahrami, Mohammad Al Zein, Ali H. Eid, et al.
Journal of Clinical and Experimental Hepatology (2025), pp. 102558-102558
Closed Access
Boosting CAR-T cell therapy with CRISPR technology
Liyanran Yan, Shanzi Gao, Xinhui Wang, et al.
hLife (2024) Vol. 2, Iss. 8, pp. 380-396
Open Access | Times Cited: 2
Editorial for the Special Issue “Advances in the Development of Anticancer Drugs”
Jean Fotie
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 1, pp. 641-641
Open Access | Times Cited: 1
Biophysical and Structural Characterization of the Interaction between Human Galectin-3 and the Lipopolysaccharide from Pseudomonas aeruginosa
Luciano Pirone, María Pia Lenza, Sonia Di Gaetano, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2895-2895
Open Access | Times Cited: 1
Melanoma-associated fibroblasts in tumor-promotion flammation and antitumor immunity: novel mechanisms and potential immunotherapeutic strategies
Qiujun Zhou, Xiaoliang Jin, Ying Zhao, et al.
Human Molecular Genetics (2024) Vol. 33, Iss. 13, pp. 1186-1193
Open Access | Times Cited: 1
In Vitro Antioxidant and In Vitro Cytotoxic Potentials of Ancardium occidentale Linn. Against Hep G2 Cell Lines
G. Shobana, Nayomi John, G. Hariharan, et al.
Advances in medical diagnosis, treatment, and care (AMDTC) book series (2024), pp. 327-342
Closed Access
Chemotherapy resistance in acute myeloid leukemia is associated with decreased anti-tumor immune response through MHC molecule and B7 family members
Jing Ge, Xiaoxuan Yin, Xin Sun, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Do we need alternative PD-1 inhibitors for the treatment of renal cell carcinoma?
Matteo Rosellini, Andrea Marchetti, Elisa Tassinari, et al.
Expert Opinion on Biological Therapy (2024) Vol. 24, Iss. 6, pp. 411-414
Open Access
From immunomodulation to therapeutic prospects: Unveiling the biology of butyrophilins in cancer
Fatemeh Mehdikhani, Aysa Bahar, Marzieh Bashi, et al.
Cell Biochemistry and Function (2024) Vol. 42, Iss. 5
Closed Access
Multifaceted role of phytoconstituents based nano drug delivery systems in combating TNBC: A paradigm shift from chemical to natural
Anandita Nair, Roshni Singh, Namrata Gautam, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9207-9226
Closed Access
Silver Nanoparticles with Modified Synthesis Use Sodium Borohydride Reducing Agent and Okra (Abelmoschus Esculentus L.) Raw Polysaccharide Extract as an Anti-Colon Cancer
Ally Kafesa, Win Darmanto, Sri Puji Wastuti Wahyuningsih
Trends in Sciences (2024) Vol. 21
Open Access
A comprehensive prognostic and immune analysis of LAPTM4B in pan-cancer and Philadelphia chromosome-positive acute lymphoblastic leukemia
Hui Zhou, Yuyao Yi, Wei He, et al.
Research Square (Research Square) (2024)
Open Access
Neurological Complications of Immune Check Point Inhibitors
Sri Raghav Sista, Naveen Kumar Paramasivan, Divyanshu Dubey
Elsevier eBooks (2024)
Closed Access
VSIG-3/IGSF11 silencing in A2058 melanoma cells simultaneously suppresses melanoma progression and induces anti-tumoral cytokine profile in human T cells: In silico and in vitro study
Najibeh Shekari, Dariush Shanehbandi, Elham Baghbani, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access
Novel Peptide-Based 68Ga-Labeled Radiotracer for Preclinical Studies of TIM3 Expression
Jinping Tao, Fei Wang, Ziqing Zeng, et al.
Molecular Pharmaceutics (2024) Vol. 22, Iss. 1, pp. 270-283
Closed Access
Elevated Galectin-3 levels in the tumor microenvironment of ovarian cancer – implication of ROS mediated suppression of NK cell antitumor response via tumor-associated neutrophils
Veronika Karlsson, Ebba Stål, Emma Stoopendahl, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
Page 1

Scroll to top